HLA-G orchestrates the early interaction of human trophoblasts with the maternal niche

Frontiers in Immunology

Volumn 6, Issue MAR, 2015, Pages

  Gregori, Silvia ^a   Amodio, Giada ^a   Quattrone, Federica ^b   Panina Bordignon, Paola ^b  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Dendritic cells; HLA G; IL 10; T regulatory cells; Trophoblasts; Vascular remodeling

Indexed keywords

ALPHA2 INTEGRIN; CHORIONIC GONADOTROPIN; HEAT SHOCK PROTEIN 70; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 8; PLACENTAL GROWTH FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; DECIDUA; DENDRITIC CELL; ENDOMETRIUM; FEMALE; FETUS; HORMONAL REGULATION; HUMAN; MOLECULAR INTERACTION; TROPHOBLAST; UNFOLDED PROTEIN RESPONSE;

EID: 84926655725     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00128     Document Type: Article

References (102)

1. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol (2006) 6(8):584-94. doi:10.1038/nri1897.
2. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet (2001) 2(7):538-48. doi:10.1038/35080570.
3. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science (2005) 308(5728):1592-4. doi:10.1126/science.1111726.
4. Pfeffer PL, Pearton DJ. Trophoblast development. Reproduction (2012) 143(3):231-46. doi:10.1530/REP-11-0374.
5. Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocr Rev (2006) 27(1):17-46. doi:10.1210/er.2004-0021.
6. Harper MJ. The implantation window. Baillieres Clin Obstet Gynaecol (1992) 6(2):351-71. doi:10.1016/S0950-3552(05)80092-6.
7. Brosens JJ, Parker MG, McIndoe A, Pijnenborg R, Brosens IA. A role for menstruation in preconditioning the uterus for successful pregnancy. Am J Obstet Gynecol (2009) 200(6):e1-6. doi:10.1016/j.ajog.2008.11.037.
8. Fishel SB, Edwards RG, Evans CJ. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro. Science (1984) 223(4638):816-8. doi:10.1126/science.6546453.
9. Jurisicova A, Antenos M, Kapasi K, Meriano J, Casper RF. Variability in the expression of trophectodermal markers beta-human chorionic gonadotrophin, human leukocyte antigen-G and pregnancy specific beta-1 glycoprotein by the human blastocyst. Hum Reprod (1999) 14(7):1852-8. doi:10.1093/humrep/14.7.1852.
10. Han SW, Lei ZM, Rao CV. Treatment of human endometrial stromal cells with chorionic gonadotropin promotes their morphological and functional differentiation into decidua. Mol Cell Endocrinol (1999) 147(1-2):7-16. doi:10.1016/S0303-7207(98)00240-8.
11. Perrier d'Hauterive S, Charlet-Renard C, Berndt S, Dubois M, Munaut C, Goffin F, et al. Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium. Hum Reprod (2004) 19(11):2633-43. doi:10.1093/humrep/deh450.
12. Berndt S, Perrier d'Hauterive S, Blacher S, Pequeux C, Lorquet S, Munaut C, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J (2006) 20(14):2630-2. doi:10.1096/fj.06-5885fje.
13. Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V, Perrier d'Hauterive S. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod Immunol (2010) 85(1):93-8. doi:10.1016/j.jri.2009.11.008.
14. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med (2006) 12(9):1065-74. doi:10.1038/nm1452.
15. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest (2014) 124(5):1872-9. doi:10.1172/JCI68107.
16. Kosaka K, Fujiwara H, Tatsumi K, Yoshioka S, Sato Y, Egawa H, et al. Human chorionic gonadotropin (HCG) activates monocytes to produce interleukin-8 via a different pathway from luteinizing hormone/HCG receptor system. J Clin Endocrinol Metab (2002) 87(11):5199-208. doi:10.1210/jc.2002-020341.
17. Wan H, Versnel MA, Leijten LM, van Helden-Meeuwsen CG, Fekkes D, Leenen PJ, et al. Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J Leukoc Biol (2008) 83(4):894-901. doi:10.1189/jlb.0407258.
18. Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol (2009) 182(9):5488-97. doi:10.4049/jimmunol.0803177.
19. Siiteri PK, Febres F, Clemens LE, Chang RJ, Gondos B, Stites D. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann N Y Acad Sci (1977) 286:384-97. doi:10.1111/j.1749-6632.1977.tb29431.x.
20. Szekeres-Bartho J, Halasz M, Palkovics T. Progesterone in pregnancy; receptor-ligand interaction and signaling pathways. J Reprod Immunol (2009) 83(1-2):60-4. doi:10.1016/j.jri.2009.06.262.
21. Xu L, Dong B, Wang H, Zeng Z, Liu W, Chen N, et al. Progesterone suppresses Th17 cell responses, and enhances the development of regulatory T cells, through thymic stromal lymphopoietin-dependent mechanisms in experimental gonococcal genital tract infection. Microbes Infect (2013) 15(12):796-805. doi:10.1016/j.micinf.2013.06.012.
22. Mao G, Wang J, Kang Y, Tai P, Wen J, Zou Q, et al. Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice. Endocrinology (2010) 151(11):5477-88. doi:10.1210/en.2010-0426.
23. Halasz M, Szekeres-Bartho J. The role of progesterone in implantation and trophoblast invasion. J Reprod Immunol (2013) 97(1):43-50. doi:10.1016/j.jri.2012.10.011.
24. Yie SM, Li LH, Li GM, Xiao R, Librach CL. Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro. Hum Reprod (2006) 21(1):46-51. doi:10.1093/humrep/dei305.
25. Nadkarni S, McArthur S. Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity. Curr Opin Pharmacol (2013) 13(4):576-81. doi:10.1016/j.coph.2013.05.007.
26. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol (2004) 173(4):2227-30. doi:10.4049/jimmunol.173.4.2227.
27. Polanczyk MJ, Hopke C, Huan J, Vandenbark AA, Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol (2005) 170(1-2):85-92. doi:10.1016/j.jneuroim.2005.08.023.
28. Schumacher A, Costa SD, Zenclussen AC. Endocrine factors modulating immune responses in pregnancy. Front Immunol (2014) 5:196. doi:10.3389/fimmu.2014.00196.
29. Castelli EC, Veiga-Castelli LC, Yaghi L, Moreau P, Donadi EA. Transcriptional and posttranscriptional regulations of the HLA-G gene. J Immunol Res (2014) 2014:734068. doi:10.1155/2014/734068.
30. Curigliano G, Criscitiello C, Gelao L, Goldhirsch A. Molecular pathways: human leukocyte antigen G (HLA-G). Clin Cancer Res (2013) 19(20):5564-71. doi:10.1158/1078-0432.CCR-12-3697.
31. Ellis SA, Sargent IL, Redman CW, McMichael AJ. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology (1986) 59(4):595-601.
32. Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod (1995) 10(Suppl 2):14-21. doi:10.1093/humrep/10.suppl_2.14.
33. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol (2003) 171(3):1376-84. doi:10.4049/jimmunol.171.3.1376.
34. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol (2008) 29(7):313-21. doi:10.1016/j.it.2008.02.012.
35. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol (2008) 29(3):125-32. doi:10.1016/j.it.2007.11.005.
36. Dong Y, Lieskovska J, Kedrin D, Porcelli S, Mandelboim O, Bushkin Y. Soluble nonclassical HLA generated by the metalloproteinase pathway. Hum Immunol (2003) 64(8):802-10. doi:10.1016/S0198-8859(03)00093-4.
37. Rizzo R, Trentini A, Bortolotti D, Manfrinato MC, Rotola A, Castellazzi M, et al. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. Mol Cell Biochem (2013) 381(1-2):243-55. doi:10.1007/s11010-013-1708-5.
38. Amodio G, Sales de Albuquerque R, Gregori S. New insights into HLA-G mediated tolerance. Tissue Antigens (2014) 84(3):255-63. doi:10.1111/tan.12427.
39. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science (1990) 248(4952):220-3. doi:10.1126/science.2326636.
40. Gonen-Gross T, Goldman-Wohl D, Huppertz B, Lankry D, Greenfield C, Natanson-Yaron S, et al. Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface. PLoS One (2010) 5(1):e8941. doi:10.1371/journal.pone.0008941.
41. Morales PJ, Pace JL, Platt JS, Langat DK, Hunt JS. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology (2007) 122(2):179-88. doi:10.1111/j.1365-2567.2007.02623.x.
42. Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol (2003) 171(11):6215-24. doi:10.4049/jimmunol.171.11.6215.
43. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J (2005) 19(7):681-93. doi:10.1096/fj.04-2078rev.
44. Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, Horejsi V, et al. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J Immunol (2005) 175(8):4866-74. doi:10.4049/jimmunol.175.8.4866.
45. Bai SX, Wang YL, Qin L, Xiao ZJ, Herva R, Piao YS. Dynamic expression of matrix metalloproteinases (MMP-2,-9 and-14) and the tissue inhibitors of MMPs (TIMP-1,-2 and-3) at the implantation site during tubal pregnancy. Reproduction (2005) 129(1):103-13. doi:10.1530/rep.1.00283.
46. Guo Y, Lee CL, So KH, Gao J, Yeung WS, Yao Y, et al. Soluble human leukocyte antigen-g5 activates extracellular signal-regulated protein kinase signaling and stimulates trophoblast invasion. PLoS One (2013) 8(10):e76023. doi:10.1371/journal.pone.0076023.
47. McIntire RH, Sifers T, Platt JS, Ganacias KG, Langat DK, Hunt JS. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords. Placenta (2008) 29(7):631-8. doi:10.1016/j.placenta.2008.04.007.
48. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A (1997) 94(21):11520-5. doi:10.1073/pnas.94.21.11520.
49. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol (2006) 4(1):e9. doi:10.1371/journal.pbio.0040009.
50. Li CHB, Nicotra ML, Strominger JL. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci U S A (2009) 106(14):5767-72. doi:10.1073/pnas.0901173106.
51. Rajagopalan S, Long EO. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodelling. Proc Natl Acad Sci U S A (2012) 109(50):20596-601. doi:10.1073/pnas.1208248109.
52. Lombardelli L, Aguerre-Girr M, Logiodice F, Kullolli O, Casart Y, Polgar B, et al. HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4(+) T cells and macrophages. J Immunol (2013) 191(7):3651-62. doi:10.4049/jimmunol.1300567.
53. Amodio G, Mugione A, Sanchez AM, Vigano P, Candiani M, Somigliana E, et al. HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy. Hum Immunol (2013) 74(4):406-11. doi:10.1016/j.humimm.2012.11.031.
54. Hsu P, Santner-Nanan B, Joung S, Peek MJ, Nanan R. Expansion of CD4(+) HLA-G(+) T cell in human pregnancy is impaired in pre-eclampsia. Am J Reprod Immunol (2014) 71(3):217-28. doi:10.1111/aji.12195.
55. Sedlmayr P, Morales P, Trummer S, Wascher K, Azzola D, Blaschitz A, et al. Absence of HLA-G expression in macrophages of human decidua. Am J Reprod Immunol (2002) 48(2):96-102. doi:10.1034/j.1600-0897.2002.01116.x.
56. Petroff MG, Sedlmayr P, Azzola D, Hunt JS. Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J Reprod Immunol (2002) 56(1-2):3-17. doi:10.1016/S0165-0378(02)00024-4.
57. Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, et al. Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol (2012) 181(6):2149-60. doi:10.1016/j.ajpath.2012.08.032.
58. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol (2002) 32(2):311-5. doi:10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.0.CO;2-8.
59. Noci I, Fuzzi B, Rizzo R, Melchiorri L, Criscuoli L, Dabizzi S, et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod (2005) 20(1):138-46. doi:10.1093/humrep/deh572.
60. Rebmann V, Switala M, Eue I, Grosse-Wilde H. Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study. Hum Reprod (2010) 25(7):1691-8. doi:10.1093/humrep/deq120.
61. Das P, Ezashi T, Schulz LC, Westfall SD, Livingston KA, Roberts RM. Effects of fgf2 and oxygen in the bmp4-driven differentiation of trophoblast from human embryonic stem cells. Stem Cell Res (2007) 1(1):61-74. doi:10.1016/j.scr.2007.09.004.
62. Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci (2011) 68(3):341-52. doi:10.1007/s00018-010-0578-1.
63. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med (2003) 198(8):1201-12. doi:10.1084/jem.20030305.
64. Kopcow HDAD, Chen X, Rybalov B, Andzelm MM, Ge B, Strominger JL. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci U S A (2005) 102(43):15563-8. doi:10.1073/pnas.0507835102.
65. Lash GE, Robson SC, Bulmer JN. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta (2010) 31(Suppl):S87-92. doi:10.1016/j.placenta.2009.12.022.
66. Cerdeira AS, Rajakumar A, Royle CM, Lo A, Husain Z, Thadhani RI, et al. Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol (2013) 190(8):3939-48. doi:10.4049/jimmunol.1202582.
67. Bulmer JN, Lash GE. Human uterine natural killer cells: a reappraisal. Mol Immunol (2005) 42(4):511-21. doi:10.1016/j.molimm.2004.07.035.
68. Kammerer U, Eggert AO, Kapp M, McLellan AD, Geijtenbeek TB, Dietl J, et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol (2003) 162(3):887-96. doi:10.1016/S0002-9440(10)63884-9.
69. Plaks V, Birnberg T, Berkutzki T, Sela S, BenYashar A, Kalchenko V, et al. Uterine DCs are crucial for decidua formation during embryo implantation in mice. J Clin Invest (2008) 118(12):3954-65. doi:10.1172/JCI36682.
70. Heikkinen J, Mottonen M, Komi J, Alanen A, Lassila O. Phenotypic characterization of human decidual macrophages. Clin Exp Immunol (2003) 131(3):498-505. doi:10.1046/j.1365-2249.2003.02092.x.
71. McIntire RH, Ganacias KG, Hunt JS. Programming of human monocytes by the uteroplacental environment. Reprod Sci (2008) 15(5):437-47. doi:10.1177/1933719107314065.
72. Hunt JS, Petroff MG. IFPA senior award lecture: reproductive immunology in perspective-reprogramming at the maternal-fetal interface. Placenta (2013) 34(Suppl):S52-5. doi:10.1016/j.placenta.2012.12.005.
73. Gustafsson C, Mjosberg J, Matussek A, Geffers R, Matthiesen L, Berg G, et al. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One (2008) 3(4):e2078. doi:10.1371/journal.pone.0002078.
74. McIntire RH, Morales PJ, Petroff MG, Colonna M, Hunt JS. Recombinant HLA-G5 and-G6 drive U937 myelomonocytic cell production of TGF-beta1. J Leukoc Biol (2004) 76(6):1220-8. doi:10.1189/jlb.0604337.
75. Ban YL, Kong BH, Qu X, Yang QF, Ma YY. BDCA-1+, BDCA-2+ and BDCA-3+ dendritic cells in early human pregnancy decidua. Clin Exp Immunol (2008) 151(3):399-406. doi:10.1111/j.1365-2249.2007.03576.x.
76. Hsu P, Nanan RK. Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol (2014) 5:125. doi:10.3389/fimmu.2014.00125.
77. Blois SM, Alba Soto CD, Tometten M, Klapp BF, Margni RA, Arck PC. Lineage, maturity, and phenotype of uterine murine dendritic cells throughout gestation indicate a protective role in maintaining pregnancy. Biol Reprod (2004) 70(4):1018-23. doi:10.1095/biolreprod.103.022640.
78. Laskarin G, Kammerer U, Rukavina D, Thomson AW, Fernandez N, Blois SM. Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am J Reprod Immunol (2007) 58(3):255-67. doi:10.1111/j.1600-0897.2007.00511.x.
79. Schumacher A, Zenclussen AC. Regulatory T cells: regulators of life. Am J Reprod Immunol (2014) 72(2):158-70. doi:10.1111/aji.12238.
80. Mjosberg J, Berg G, Jenmalm MC, Ernerudh J. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod (2010) 82(4):698-705. doi:10.1095/biolreprod.109.081208.
81. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology (2004) 112(1):38-43. doi:10.1111/j.1365-2567.2004.01869.x.
82. Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF, et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood (2010) 116(6):935-44. doi:10.1182/blood-2009-07-234872.
83. Du MR, Guo PF, Piao HL, Wang SC, Sun C, Jin LP, et al. Embryonic trophoblasts induce decidual regulatory T cell differentiation and maternal-fetal tolerance through thymic stromal lymphopoietin instructing dendritic cells. J Immunol (2014) 192(4):1502-11. doi:10.4049/jimmunol.1203425.
84. Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med (2013) 19(6):739-46. doi:10.1038/nm.3179.
85. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol (1999) 11(5):803-11. doi:10.1093/intimm/11.5.803.
86. Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med (2012) 18(12):1754-67. doi:10.1038/nm.3012.
87. Morimoto RI, Santoro MG. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol (1998) 16(9):833-8. doi:10.1038/nbt0998-833.
88. Voss AK, Thomas T, Gruss P. Mice lacking HSP90beta fail to develop a placental labyrinth. Development (2000) 127(1):1-11.
89. Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, et al. Uterine selection of human embryos at implantation. Sci Rep (2014) 4:3894. doi:10.1038/srep03894.
90. Calderwood SK, Mambula SS, Gray PJ Jr, Theriault JR. Extracellular heat shock proteins in cell signaling. FEBS Lett (2007) 581(19):3689-94. doi:10.1016/j.febslet.2007.04.044.
91. Matzinger P. The danger model: a renewed sense of self. Science (2002) 296(5566):301-5. doi:10.1126/science.1071059.
92. Hayoun D, Kapp T, Edri-Brami M, Ventura T, Cohen M, Avidan A, et al. HSP60 is transported through the secretory pathway of 3-MCA-induced fibrosarcoma tumour cells and undergoes N-glycosylation. FEBS J (2012) 279(12):2083-95. doi:10.1111/j.1742-4658.2012.08594.x.
93. Hightower LE, Guidon PT Jr. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J Cell Physiol (1989) 138(2):257-66. doi:10.1002/jcp.1041380206.
94. Mansilla MJ, Costa C, Eixarch H, Tepavcevic V, Castillo M, Martin R, et al. Hsp70 regulates immune response in experimental autoimmune encephalomyelitis. PLoS One (2014) 9(8):e105737. doi:10.1371/journal.pone.0105737.
95. Multhoff G. Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia (2002) 18(6):576-85. doi:10.1080/0265673021000017109.
96. van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol (2005) 5(4):318-30. doi:10.1038/nri1593.
97. Ibrahim EC, Morange M, Dausset J, Carosella ED, Paul P. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines. Cell Stress Chaperones (2000) 5(3):207-18. doi:10.1379/1466-1268(2000)005<0207:HSAAIE>2.0.CO;2.
98. Xiao X, Zuo X, Davis AA, McMillan DR, Curry BB, Richardson JA, et al. HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J (1999) 18(21):5943-52. doi:10.1093/emboj/18.21.5943.
99. Shkoda A, Ruiz PA, Daniel H, Kim SC, Rogler G, Sartor RB, et al. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology (2007) 132(1):190-207. doi:10.1053/j.gastro.2006.10.030.
100. Hasnain SZ, Tauro S, Das I, Tong H, Chen AC, Jeffery PL, et al. IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells. Gastroenterology (2013) 144(2):357-368e9. doi:10.1053/j.gastro.2012.10.043.
101. Cheng SB, Sharma S. Interleukin-10: a pleiotropic regulator in pregnancy. Am J Reprod Immunol (2014). doi:10.1111/aji.12329.
102. Ghosh R, Lipson KL, Sargent KE, Mercurio AM, Hunt JS, Ron D, et al. Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS One (2010) 5(3):e9575. doi:10.1371/journal.pone.0009575.